Stock Fundamentals

Company Information

Company Name
Kiniksa Pharmaceuticals Ltd
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: BMG5269C1010
CIK: 0001730430
CUSIP: G5269C101
Currency: USD
Full Time Employees: 366
Phone: 44 78 1431 9100
Fiscal Year End: December
IPO Date: May 24, 2018
Description:

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.

Address:

105 Piccadilly, London, United Kingdom, W1J 7NJ

Directors & Officers

Name Title Year Born
Mr. Sanj K. Patel CEO & Chairman of the Board 1969
Mr. Mark A. Ragosa C.F.A. Executive VP & CFO 1974
Mr. Ross Michael Moat Executive VP, COO & Principal Operating Officer 1980
Dr. John F. Paolini FACC, M.D., Ph.D. Executive VP & Chief Medical Officer 1965
Mr. Eben Tessari Consultant 1982
Mr. Michael R. Megna CPA Senior VP & Chief Accounting Officer 1971
Ms. Mei Jang Senior VP & Chief Technical Officer NA
Mr. Jonathan Kirshenbaum Investor Relations Officer NA
Mr. Douglas Barry Senior VP, Chief Legal Officer & Secretary NA
Ms. Martina Struck Ph.D. Senior VP & Chief Regulatory Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 09, 2026 Ross Moat N/A Sale 1.70K $46.69 $79.51K
Apr 09, 2026 Michael R Megna N/A Sale 6.63K $46.69 $309.32K
Apr 06, 2026 Barry D Quart N/A Sale 6.90K $50.00 $345.05K
Apr 06, 2026 Ross Moat N/A Sale 2.37K $48.58 $114.99K
Apr 06, 2026 Sanj K Patel N/A Sale 7.28K $50.01 $363.97K
Feb 12, 2026 Barry D Quart N/A Sale 2.69K $45.00 $121.05K
Feb 10, 2026 Barry D Quart N/A Sale 110.00 $45.00 $4.95K
Feb 09, 2026 Mark Ragosa N/A Sale 17.85K $43.28 $772.33K
Feb 04, 2026 Barry D Quart N/A Sale 2.60K $45.02 $117.14K
Feb 03, 2026 Barry D Quart N/A Sale 12.53K $45.27 $567.14K
Feb 02, 2026 Barry D Quart N/A Sale 830.00 $45.00 $37.35K
Jan 08, 2026 Mark Ragosa N/A Sale 12.00K $41.89 $502.68K
Dec 15, 2025 Barry D Quart N/A Sale 20.13K $41.51 $835.55K
Dec 15, 2025 Eben Tessari N/A Sale 12.05K $41.56 $500.71K
Dec 08, 2025 Mark Ragosa N/A Sale 42.84K $41.49 $1.78M
Nov 26, 2025 Eben Tessari N/A Sale 200.00 $42.89 $8.58K
Nov 17, 2025 Eben Tessari N/A Sale 12.47K $41.24 $514.26K
Nov 12, 2025 Mark Ragosa N/A Sale 19.90K $40.94 $814.71K
Oct 31, 2025 John F Paolini N/A Sale 82.54K $37.14 $3.07M
Oct 28, 2025 Mark Ragosa N/A Sale 100.00 $41.00 $4.10K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 6.82M Mar 31, 2026 8.87% $0.02 315.35%
Rubric Capital Management LP 3.75M Mar 31, 2026 4.87% $1.91 12.66%
Vanguard Group Inc 3.11M Dec 31, 2025 4.05% $0.00 1.63%
Baker Bros Advisors LP 2.83M Mar 31, 2026 3.67% $0.78 0.00%
TANG CAPITAL MANAGEMENT LLC 2.26M Mar 31, 2026 2.94% $5.53 0.00%
Vanguard Portfolio Management, LLC 1.77M Mar 31, 2026 2.30% $0.00 0.00%
Acadian Asset Management LLC 1.34M Mar 31, 2026 1.74% $0.09 41,738.23%
Vanguard Capital Management, LLC 1.33M Mar 31, 2026 1.73% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 997.79K Mar 31, 2026 1.30% $0.00 -26.64%
D. E. Shaw & Co LP 959.26K Mar 31, 2026 1.25% $0.03 -22.74%
Arrowstreet Capital Limited Partnership 892.67K Mar 31, 2026 1.16% $0.02 -16.43%
Dimensional Fund Advisors, Inc. 811.92K Mar 31, 2026 1.06% $0.01 18.79%
Spruce Street Capital LP 761.06K Mar 31, 2026 0.99% $8.81 74.96%
Bank of America Corp 735.94K Mar 31, 2026 0.96% $0.00 220.86%
Qube Research & Technologies 686.85K Mar 31, 2026 0.89% $0.04 -10.37%
Connor Clark & Lunn Inv Mgmt Ltd 649.63K Mar 31, 2026 0.84% $0.07 -12.13%
BNP Paribas Arbitrage, SA 647.73K Mar 31, 2026 0.84% $0.02 -22.13%
Point72 Asset Management, L.P. 640.96K Mar 31, 2026 0.83% $0.04 -19.59%
SG Americas Securities, LLC 640.18K Mar 31, 2026 0.83% $0.03 18.25%
Pictet Asset Manangement SA 623.29K Mar 31, 2026 0.81% $0.03 -20.85%

Shares Statistics

Shares Outstanding: 46.30M
Shares Float: 39.32M
% Insiders: 357.90%
% Institutions: 10,277.00%
Short % Float: 8.01%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.29M 1.68% ▲ 0.37% Apr 30, 2026
2 Vanguard Small Cap Index 950.95K 1.24% ▼ 0.43% Apr 30, 2026
3 Fidelity Select Health Care 820.00K 1.07% ▲ 2.50% Apr 30, 2026
4 Fidelity Select Biotechnology 637.60K 0.83% ▲ 0.00% Apr 30, 2026
5 Strategic Advisers Fidelity US TtlStk 586.98K 0.76% ▲ 4.45% Apr 30, 2026
6 Fidelity Small Cap Growth 581.26K 0.76% ▲ 0.00% Mar 31, 2026
7 Vanguard Small Cap Growth Index Inv 534.78K 0.70% ▼ 0.08% Apr 30, 2026
8 Pictet-Biotech P USD 428.59K 0.56% ▼ 10.52% Feb 28, 2026
9 Fidelity Advisor Biotechnology I 417.60K 0.54% ▲ 0.00% Apr 30, 2026
10 AB SICAV I Intl Hlth Cr AX USD 403.97K 0.53% ▼ 0.25% Apr 30, 2026

Valuation Metrics

Enterprise Value: $3.53B
Trailing P/E: 57.02
Forward P/E: 47.17

Financial Highlights

Market Cap: $3.99B
EBITDA: $94.89M
P/E Ratio: $57.02
Book Value: $8.22
Earnings/Share: $0.91
Profit Margin: 9.69%
Operating Margin: 13.66%
ROA (TTM): 8.18%
ROE (TTM): 13.74%
Revenue (TTM): $754.04M
Revenue/Share (TTM): $10.03
Earnings Growth (YOY): 145.50%
Revenue Growth (YOY): 55.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.79x 0.01x 0.26x N/A 0.03x
2024-12-31 3.30x 0.00x 0.24x N/A -0.06x
2023-12-31 4.34x 0.01x 0.17x N/A -0.16x
2022-12-31 5.16x 0.01x 0.14x 7.80x 0.25x
2021-12-31 4.38x 0.02x 0.21x -63.88x -0.02x
2020-12-31 10.46x 0.01x 0.11x -44.47x -0.01x
2019-12-31 8.68x 0.01x 0.11x -20.94x -0.01x
2018-12-31 7.37x 0.00x 0.13x N/A 0.00x
2017-12-31 2.70x 0.00x 2.89x N/A 0.00x
2016-12-31 24.47x 0.00x 1.46x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KNSA.US!